This is the result of a collaboration across multiple institutes (Dana-Farber, MassGeneral News, and Genentech) with some fantastic co-authors: Sarah Abou Alaiwi, Wenxin (Vincent) Xu, Vivek Naranbhai, MD, PhD, DPhil, Toni Choueiri, MD, Matt Freedman, Sasha Gusev, and many more.

Just registered for the 2022 LUNGSTRONG 5K Run/1.5K Walk. Join me and the rest of MGH Thoracic Oncology for a great event on May 15th to support lung cancer research. LUNGSTRONG lungstrong.org/5k-run-1-5m-wa…

#MassGeneral physician Vivek Naranbhai, MD, PhD, DPhil MD was quoted in Parade Mag's article on the most effective combinations of #COVID vaccine boosters. parade.com/1362913/michel…

Congratulations to Ragon Steering Committee member Mary Carrington on her election to the American Academy of Arts & Sciences! NCI Center for Cancer Research Frederick National Laboratory American Academy of Arts & Sciences View the full list of new members: amacad.org/new-members-20…

Very lucky to attend Harvard T.H. Chan School of Public Health graduation to watch Dr Kevin Ramsamy graduate with his Harvard MPH. A South African urologist who wants to make an impact! Fitting that Mamphele Ramphele was the speaker! Amandla!

Lots of credit to our multidisciplinary team: Oncology - Jarushka Naidoo, Dr. Julie Brahmer, Kerry Reynolds, Vivek Naranbhai, MD, PhD, DPhil Rheumatology - Laura Cappelli And of course Dermatology - Eugene Semenov, MD & the whole team - Thomas Le, Varsha Parthasarathy, M.D. Izzy Brown June Deng, etc

excited to share with you our new preprint describing vaccine effectiveness over time where we find that for immunosuppressed patients with cancer receiving immunosuppressive treatment, the booster effect may wane, and perhaps could be considered on a more frequent basis (2/17)

NEW PREPRINT - first output from the International Tuberculosis Host Genetics Consortium medrxiv.org/content/10.110… Represents an enormous amount of work led by Haiko Schurz and Vivek Naranbhai, MD, PhD, DPhil More to follow incl summary stats so others can work on these data (MR studies, etc)

Jeff Yang MD FACS Drew Moghanaki 🐕 Katie Couric Ted Wayman And the amazing news is that multiple studies suggest lung cancer screening may be even more effective in women than in men! #ScreenHerLungs Heather Wakelee Jyoti D Patel donington Marina Garassino Narjust Florez, MD, FASCO Dr. Estela Rodriguez Erica Warner, ScD Elyse Park Jill Feldman Andrea Mckee

Beautiful work by Inbal Avraham-Davidi! Glad to be able to contribute in a small way. Integrative single cell and spatial transcriptomics of colorectal cancer reveals multicellular functional units that support tumor progression biorxiv.org/content/10.110…

If you are feeling adventurous and fancy living in the world’s most liveable city Melbourne, Australia - we are looking for someone to join the “single cell” team 😎 in The Dawson Lab Peter Mac Research

1/ Happy to share our latest work looking at the association of germline variants with irAEs in Nature Medicine. An international effort led by🌟Stefan Groha w/co-seniors #GusevLab Dana-Farber Division of Population Sciences #FreedmanLab & Toni Choueiri, MD Dana-Farber nature.com/articles/s4159… OncoAlert DF/HCC

Our latest publication is out now! - Mathematical Model predicts long-term effectiveness of COVID-19 vaccine booster doses in different patient populations. Now available PNASNews. Cancer Biophysics Lab Mass General Cancer Center Mass General MDs @MassGeneralBrigham pnas.org/doi/10.1073/pn…

Congratulations to Catherine Meador, MD, PhD and co-authors for their publication in Clinical Lung Cancer reporting rates of Covid-19 vaccination among patients with lung cancer – now online! Vivek Naranbhai, MD, PhD, DPhil, Chris Nabel, MD PhD, Balazs Lab, Justin Gainor Mass General Cancer Center Read @: sciencedirect.com/science/articl…

Big thanks also to fellow authors Tom Parks, Tom Yates, Marlo Möller Vivek Naranbhai, MD, PhD, DPhil & rest of ITHGC. And personal heads up to NIHR UCLH Biomedical Research Centre for support. We welcome comments & critique! And to save you scrolling back up, here's the link to paper: medrxiv.org/content/10.110… 6/6

(1/3) Excited to share our work on genomic and transcriptomic predictors of response to PD-(L)1 inhibitors in NSCLC Nature Genetics; nearly 400 pts and growing, forming the SU2C/Mark Foundation cohort nature.com/articles/s4158…

‘@fattsann Man Charurat Chenfeng Xiong Vivek Naranbhai, MD, PhD, DPhil Patrick Dakum Dr. Gambo Aliyu Ifedayo Adetifa Alash'le Abimiku et al. discuss how to engage stakeholders for successful #DataScience research to promote health. #SDG3 bit.ly/3INnRPI

Congrats to our collaborative group and especially to Reza Zonozi LucyClaire Aaron Shulkin and Vivek naranbhai on our new paper characterizing SARS-CoV-2 T cell responses and the value of the COVID-19 vaccines in B cell-deficient individuals.

Cc Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 #IDtwitter x.com/tomayates/stat…

Our new article for #COVIDVACCINE with Edwin L. Steele Laboratories, lancemunn @CoreyHardin2 Justin Gainor Vivek Naranbhai, MD, PhD, DPhil Chrysovalantis Voutouri is out! In silico clinical studies for optimal COVID-19 vaccination schedules in patients with cancer: Cell Reports Medicine cell.com/cell-reports-m…